cbdMD appoints CEO/CFO Ronan Kennedy to Board, expanding to 5 members

cbdMD, Inc.

Expanded Board from 4 to 5; Kennedy appointed effective Dec 18/19, 2024.
Kennedy will not receive additional compensation for board service.
Three of five Board members meet independence standards; Kennedy is not independent.
Kennedy's term expires at the 2025 annual shareholder meeting; he will not serve on committees.
Press release highlights Kennedy's role in cost optimization and cash position improvement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.